What is the current Price Target for the Kezar Life Sciences Inc stock?

The average Kezar Life Sciences Inc target price is $6.12. This is -16.05% lower than the current stock price. The highest price target is 0.82%, the lowest is -30.73%. 3 Analysts have issued a price target Kezar Life Sciences Inc 2027 .

How high will the Kezar Life Sciences Inc stock rise?

No reliable answer can be given as to how high the Kezar Life Sciences Inc stock will rise. The performance of stocks, including the Kezar Life Sciences Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Kezar Life Sciences Inc stock today?

The performance of Kezar Life Sciences Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Kezar Life Sciences Inc stock fall?

The decline in Kezar Life Sciences Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Kezar Life Sciences Inc Forecast, price target & analysts

$7.29

0.00%

Nasdaq, Fri, Sep 18 2026.

ISIN

US49372L1008

Symbol

KZR

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Kezar Life Sciences Inc Target price 2026 - Analyst rating & recommendation

Kezar Life Sciences Inc Classifications & Recommendation

Buy

44%

Hold

56%

Kezar Life Sciences Inc Price Target

Target Price	$6.12
Price	$7.29
Deviation	16.05% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target Kezar Life Sciences Inc 2027 . The average Kezar Life Sciences Inc target price is $6.12. This is 16.05% register free of charge lower than the current stock price. The highest price target is $7.35 0.82% register free of charge , the lowest is $5.05 30.73% register free of charge .
	A rating was issued by 9 analysts: 4 Analysts recommend Kezar Life Sciences Inc to buy, 5 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Kezar Life Sciences Inc stock has an average upside potential 2027 of 16.05% register free of charge . Most analysts recommend the Kezar Life Sciences Inc stock at Hold.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '25	2026 Estimates
Earnings Per Share $	-7.66	-3.17
	33.33%	58.62%
P/E		negative

5 Analysts have issued a Kezar Life Sciences Inc forecast for earnings per share. The average Kezar Life Sciences Inc EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-7.66	33.33%
2026	$-3.17 58.62% unlock
2027	$-2.89 8.83% unlock
2028	$-3.34 15.57% unlock
2029	$-2.42 27.54% unlock
2030	$-0.06 97.52% unlock
2031	$2.36 4,033.33% unlock
2032	$5.70 141.53% unlock
2033	$9.20 61.40% unlock

Current
2026	-2.30 141.67% unlock
2027	-2.53 10.00% unlock
2028	-2.18 13.83% unlock
2029	-3.01 38.07% unlock
2030	-120.30 3,896.68% unlock

Kezar Life Sciences Inc...

Current Kezar Life Sciences Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Jefferies	Locked ➜ Locked	Locked	Oct 17 2025
Wells Fargo	Locked ➜ Locked	Locked	Oct 17 2025
William Blair	Locked ➜ Locked	Locked	Oct 17 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jul 16 2025
Wells Fargo	Locked ➜ Locked	Locked	Dec 19 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Dec 02 2024
Wells Fargo	Locked ➜ Locked	Locked	Nov 14 2024

Analyst Rating	Date
Locked Jefferies: Locked ➜ Locked	Oct 17 2025
Locked Wells Fargo: Locked ➜ Locked	Oct 17 2025
Locked William Blair: Locked ➜ Locked	Oct 17 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jul 16 2025
Locked Wells Fargo: Locked ➜ Locked	Dec 19 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Dec 02 2024
Locked Wells Fargo: Locked ➜ Locked	Nov 14 2024

Discover more stocks with a high price target

NIO ADR 100.10%

Alibaba Group Holding Ltd 68.75%

Infineon 65.25%

Tencent Holdings Ltd. 63.10%

Rheinmetall 61.30%

TUI 56.70%

Adyen 53.16%

Siemens Energy 49.14%

Adidas 46.64%

Uber Technologies 46.13%

BYD 40.95%

NVIDIA 37.67%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now